Splenic artery steal syndrome in patients with orthotopic liver transplant: Where to embolize the splenic artery?


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 03 08 2021
accepted: 27 01 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 22 4 2022
Statut: epublish

Résumé

This study compared proximal and distal embolization of the splenic artery (SA) in patients with splenic artery steal syndrome (SAS) after orthotopic liver transplantation (OLT) regarding post interventional changes of liver function to identify an ideal location of embolization. 85 patients with SAS after OLT treated with embolization of the SA between 2007 and 2017 were retrospectively reviewed. Periinterventional DSA was used to assess treatment success and to stratify patients according to the site of embolization. Liver function was assessed using following laboratory values: bilirubin, albumin, gamma-glutamyl transferase, glutamat-pyruvat-transaminase (GPT), glutamic-oxaloacetic transaminase (GOT), Alkaline Phosphatase (ALP), aPTT, prothrombin time and thrombocyte count. Descriptive statistics were used to summarize the data. Median laboratory values of pre, 1- and 3-days, as well as 1-week and 1-month post-embolization were compared between the respective embolization sites using linear mixed model regression analysis. All procedures were technically successful and showed an improved blood flow in the hepatic artery post-embolization. Ten Patients were excluded due to re -intervention or inconsistent image documentation. Pairwise comparison using linear mixed model regression analysis showed a significant difference between proximal and distal embolization for GPT (57.0 (IQR 107.5) vs. 118.0 (IQR 254.0) U/l, p = 0.002) and GOT (48.0 (IQR 48.0) vs. 81.0 (IQR 115.0) U/l, p = 0.008) 3-days after embolization as well as median thrombocyte counts 7-days after embolization (122 (IQR 108) vs. 83 (IQR 74) in thousands, p = 0.014). For all other laboratory values, no statistically significant difference could be shown with respect to the embolization site. We conclude that long-term outcomes after embolization of the SA in the scenario of SAS after OLT are irrespective of the site of embolization of the SA, whereas a proximal embolization potentially facilitates earlier normalization of liver function. Choice of technique should therefore be informed by anatomical conditions, safety considerations and preferences of the interventionalist.

Identifiants

pubmed: 35271572
doi: 10.1371/journal.pone.0263832
pii: PONE-D-21-24840
pmc: PMC8912229
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0263832

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Cardiovasc Intervent Radiol. 2011 Dec;34(6):1208-13
pubmed: 21184225
AJR Am J Roentgenol. 2003 Sep;181(3):831-8
pubmed: 12933490
Cardiovasc Intervent Radiol. 2011 Jun;34(3):522-31
pubmed: 20700592
Transpl Int. 2000;13(5):372-8
pubmed: 11052274
AJR Am J Roentgenol. 1986 Oct;147(4):657-63
pubmed: 3529892
Transplant Proc. 2011 Jun;43(5):1790-3
pubmed: 21693280
Rofo. 2001 Oct;173(10):908-13
pubmed: 11588678
Fed Proc. 1983 Apr;42(6):1662-6
pubmed: 6832383
Int J Surg. 2014 Nov;12(11):1228-34
pubmed: 25311773
J Physiol. 2001 Feb 15;531(Pt 1):193-201
pubmed: 11179403
J Vasc Interv Radiol. 2008 May;19(5):652-6
pubmed: 18440451
Cardiovasc Intervent Radiol. 2002 Jul-Aug;25(4):300-6
pubmed: 12042994
Aktuelle Radiol. 1992 Mar;2(2):55-8
pubmed: 1571371
J Trauma. 1995 Nov;39(5):818-25; discussion 826-7
pubmed: 7473996
Transpl Int. 2002 Mar;15(2-3):139-41
pubmed: 11935171
Transplant Proc. 1993 Aug;25(4):2594-6
pubmed: 8356684
N Engl J Med. 1975 Sep 11;293(11):531-41
pubmed: 168489
Transpl Int. 2010 Aug;23(8):831-41
pubmed: 20180930
Liver Transpl. 2003 Jun;9(6):596-602
pubmed: 12783401
Transplant Proc. 2007 May;39(4):1178-80
pubmed: 17524925

Auteurs

Florian N Fleckenstein (FN)

Department of Diagnostic and Interventional Radiology, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Berlin Institute of Health at Charité -Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Berlin, Germany.

Willie M Luedemann (WM)

Department of Diagnostic and Interventional Radiology, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Ahmet Kücükkaya (A)

Department of Diagnostic and Interventional Radiology, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Timo A Auer (TA)

Department of Diagnostic and Interventional Radiology, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Berlin Institute of Health at Charité -Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Berlin, Germany.

Julius Plewe (J)

Department of Abdominal Surgery, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Bernd Hamm (B)

Department of Diagnostic and Interventional Radiology, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Rolf W Günther (RW)

Department of Diagnostic and Interventional Radiology, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Uli Fehrenbach (U)

Department of Diagnostic and Interventional Radiology, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Bernhard Gebauer (B)

Department of Diagnostic and Interventional Radiology, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Gero Wieners (G)

Department of Diagnostic and Interventional Radiology, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH